Drug Profile
Mitoguazone
Alternative Names: Methyl-G; Methyl-GAG; MGBG; Mitoguazone dihydrochloride; NSC 32946; ZyrkamineLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Cancer Therapy and Research Center
- Class Antineoplastics; Guanidines
- Mechanism of Action Adenosylmethionine decarboxylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Non-Hodgkin's lymphoma; Non-small cell lung cancer; Pancreatic cancer; Prostate cancer
Most Recent Events
- 13 Nov 1998 Discontinued-Clinical for Prostate cancer in USA (IV)
- 13 Nov 1998 Discontinued-II for Non-small cell lung cancer in USA (IV)
- 13 Nov 1998 Discontinued-preregistration for Non-Hodgkin's lymphoma in USA (IV)